STOCKHOLM, SWEDEN (UroToday.com) - Presented by Emmanuel S. Antonarakis,1 Adam S. Kibel,2 George Adams,3 Lawrence I. Karsh,4 Aymen Elfiky,2 Neal D. Shore,5 Nicholas J. Vogelzang,6 John M. Corman,7 Robert C. Tyler,8 Candice McCoy,8 Todd DeVries,8 Nadeem Sheikh,8 and Charles G. Drake,1, 9 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; 2Brigham and Women’s Hospital, Harvard University, Boston, MA; 3Urology Center of Alabama, Homewood, AL; 4The Urology Center of Colorado; 5Carolina Urologic Research Center, Myrtle Beach, SC 6US Oncology Research, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; 7Virginia Mason Medical Center, Seattle, WA; 8Dendreon Corporation, Seattle, WA; 9Brady Urological Institute, Johns Hopkins University, Baltimore, MD
Click HERE to listen to an audio commentary by Robert Tyler, PhD, one of the authors of this study
Click HERE to read an exclusive report by a UroToday medical writer